The identification of AF38469: An orally bioavailable inhibitor of the VPS10P family sorting receptor Sortilin.
Schrder, T.J., Christensen, S., Lindberg, S., Langgard, M., David, L., Maltas, P.J., Eskildsen, J., Jacobsen, J., Tagmose, L., Simonsen, K.B., Biilmann Rnn, L.C., de Jong, I.E., Malik, I.J., Karlsson, J.J., Bundgaard, C., Egebjerg, J., Stavenhagen, J.B., Strandbygard, D., Thirup, S., Andersen, J.L., Uppalanchi, S., Pervaram, S., Kasturi, S.P., Eradi, P., Sakumudi, D.R., Watson, S.P.(2014) Bioorg Med Chem Lett 24: 177-180
- PubMed: 24355129
- DOI: https://doi.org/10.1016/j.bmcl.2013.11.046
- Primary Citation of Related Structures:
4N7E - PubMed Abstract:
The identification of the novel, selective, orally bioavailable Sortilin inhibitor AF38469 is described. Structure-activity relationships and syntheses are reported, along with an X-ray crystal structure of the sortilin-AF38469 protein-inhibitor complex.
Organizational Affiliation:
Neuroscience Drug Discovery, H. Lundbeck A/S, Copenhagen, Denmark.